Cost-effectiveness Analysis of Elbasvir and Grazoprevir for Treatment of Adult Patients with Chronic Hepatitis C (genotype 1b) from Russian Healthcare System Perspective
2018
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI